JPH01503705A - 脈管形成の刺激および内皮化の増進 - Google Patents

脈管形成の刺激および内皮化の増進

Info

Publication number
JPH01503705A
JPH01503705A JP62504759A JP50475987A JPH01503705A JP H01503705 A JPH01503705 A JP H01503705A JP 62504759 A JP62504759 A JP 62504759A JP 50475987 A JP50475987 A JP 50475987A JP H01503705 A JPH01503705 A JP H01503705A
Authority
JP
Japan
Prior art keywords
angiogenesis
inflammatory
proline
inflammatory compound
endothelialization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62504759A
Other languages
English (en)
Japanese (ja)
Inventor
マクオースラン　ブライアン　リチャード
Original Assignee
ビオタ・シャンティフィック・マネージメント・ピーティーワイ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ビオタ・シャンティフィック・マネージメント・ピーティーワイ・リミテッド filed Critical ビオタ・シャンティフィック・マネージメント・ピーティーワイ・リミテッド
Publication of JPH01503705A publication Critical patent/JPH01503705A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP62504759A 1986-08-18 1987-08-10 脈管形成の刺激および内皮化の増進 Pending JPH01503705A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH752186 1986-08-18
AU7521 1986-08-18

Publications (1)

Publication Number Publication Date
JPH01503705A true JPH01503705A (ja) 1989-12-14

Family

ID=3771766

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62504759A Pending JPH01503705A (ja) 1986-08-18 1987-08-10 脈管形成の刺激および内皮化の増進

Country Status (4)

Country Link
EP (1) EP0318488A4 (fr)
JP (1) JPH01503705A (fr)
WO (1) WO1988001166A1 (fr)
ZA (1) ZA876079B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03109324A (ja) * 1989-09-22 1991-05-09 Microbial Chem Res Found 血管新生阻害剤
WO1998042329A1 (fr) * 1997-03-21 1998-10-01 Mitsubishi Chemical Corporation Preventifs et/ou remedes destines a des affections provoquees par une neovascularisation anormale
US6660283B2 (en) * 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
JP2004262776A (ja) * 2003-02-21 2004-09-24 Teikoku Seiyaku Co Ltd 血管新生促進剤
MXPA06011851A (es) 2004-04-14 2006-12-14 Genentech Inc Composiciones y metodos para moduilar el desarrollo vascular.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2515189A (en) * 1948-10-12 1950-07-18 Samson Preservation of leucocytes in blood
BE626119A (fr) * 1961-12-19
US3873715A (en) * 1973-04-06 1975-03-25 Univ Miami Therapeutic agent for improving cardiovascular function
US3928587A (en) * 1974-08-16 1975-12-23 Philip Nicholas Sawyer Method of conditioning vascular systems by administering 3,5 dichloroaspirin and method of evaluating pharmaceutical compounds
GB1518333A (en) * 1975-05-30 1978-07-19 Science Union & Cie Pharmaceutical compositions containing a ypsilon-resorcylic acid derivative
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
CA1229554A (fr) * 1983-04-18 1987-11-24 Warner-Lambert Company Compose pharmaceutique topique d'acide meclofenamique
MX163953B (es) * 1984-03-27 1992-07-03 Univ New Jersey Med Procedimiento para preparar una matriz biodegradable a base de colageno
EP0294380A4 (fr) * 1986-02-18 1990-02-20 Biota Scient Management Stimulation de l'angiogenese.

Also Published As

Publication number Publication date
ZA876079B (en) 1988-06-29
EP0318488A1 (fr) 1989-06-07
EP0318488A4 (fr) 1990-02-26
WO1988001166A1 (fr) 1988-02-25

Similar Documents

Publication Publication Date Title
Hrynyk et al. Insulin and wound healing
TWI257307B (en) Pharmaceutical composition for cardiac tissue repair
Taylor et al. Protamine is an inhibitor of angiogenesis
DE60033932T2 (de) Methode und zusammensetzung zur inhibierung von kardiovaskulärer zellproliferation
US5827735A (en) Pluripotent mesenchymal stem cells and methods of use thereof
JP5607176B2 (ja) 新規ペプチドおよびその用途
US20150231312A1 (en) Advanced Heart Failure Treatment Material as Myocardial/Cardiovascular Regeneration Device
JPH06510989A (ja) 組織形成因子誘導による炎症反応の調節
CA3117723A1 (fr) Procedes de reprogrammation cellulaire
JPH02134327A (ja) 角膜内皮における創傷治癒を高める方法
JP2025157522A (ja) 細胞外マトリクスの合成を促進するグルコサミンのアミノ酸誘導体、及びこれを含む医薬組成物
JP2005518409A (ja) 心筋および末梢血管新生を促進する組成物および方法
JP3149180B2 (ja) 瘢痕治療のためのカルシウム拮抗薬の使用
JPH01503705A (ja) 脈管形成の刺激および内皮化の増進
CN108310365A (zh) 一种含mg53突变体的组合物在制备神经保护药物中的应用
WO1989001489A1 (fr) Regulation de l'angiogenese et compositions et procedes prevus a cet effet
US7820172B1 (en) Laminin-derived multi-domain peptides
RU2131246C1 (ru) Агент, ускоряющий разрастание эндотелиальных клеток
EA014296B1 (ru) Средство, активирующее стволовые клетки и/или клетки-предшественники
CA2423190C (fr) Agent angiogeniques et leurs utilisations
RU2766083C1 (ru) Биологически активная субстанция в виде биорегуляторной композиции, обладающая поддерживающим и восстановительным действием на ткани и органы, и фармакологическая композиция
JPS63502661A (ja) 脈管形成の刺激方法
Ghosh et al. Preclinical and clinical study of polysaccharide-based hydrogels
US7807628B2 (en) Therapeutic agent for dentin-pulp complex regeneration
US20240165056A1 (en) Use of tamoxifen and related compounds to reduce breast implant capsule formation and capsular contracture